Navigation Links
Study says women's health much more at risk from sleep deprivation
Date:9/7/2007

New research led by researchers at Warwick Medical School at the University of Warwick reveals that womens health is much more at risk from sleep deprivation than mens.

The researchers looked at men and women sleeping less than or equal 5 hours a night to see if their risk of having hypertension was any higher than men and women getting the recommended 7 hours or more of sleep a night. Among other problems increased hypertension does increase the risk of cardiovascular problems.

Some previous studies have indicated that sleep deprivation is also associated with an increased risk of hypertension. However that research was based on self-reported diagnosis of hypertension, and had no gender-specific analysis.

The University of Warwick led research team looked at data from The Whitehall II Cohort which studied volunteers from 20 London-based civil service departments. There were a total of 6,592 participants (4,199 men and 1,567 women). The Warwick team defined hypertension as blood pressure equal to or higher than 140/90 mm Hg or if the subject made regular use of antihypertensive medications.

The researchers found that the those women in the study group who slept less than or equal to 5 hours a night were twice as likely to suffer from hypertension than women who slept for the more recommended seven hours or more a night. The researchers found no difference between men sleeping less than 5 hours and those sleeping 7 hours or more.

Professor Francesco Cappuccio from the University of Warwicks Warwick Medical School led the research he declared that women sleeping les than 5 hours a night should try to get more sleep as:

Sustained sleep curtailment, ensuing excessive daytime sleepiness, and the higher cardiovascular risk are causes for concern. Emerging evidence also suggests a potential role for sleep deprivation as a predictor or risk factor for conditions like obesity and diabetes.


'/>"/>

Contact: Professor Francesco Cappuccio
F.P.Cappuccio@warwick.ac.uk
44-024-769-68662
University of Warwick
Source:Eurekalert

Page: 1

Related medicine news :

1. Gene study links endometriosis, infertility
2. Study reveals how stress can make you sick
3. Study points out that HIV vaccine may not be accepted easily
4. A new study surpasses Gene Therapy Hurdle
5. Tomato Sauce reduces Cancer Risk- Study
6. A question on study of Adult Stem Cell
7. Study on obesity and heart failure
8. National Lung Study in the process
9. Marijuana gateway theory strengthened by study of twins
10. Old theory of adaptation confirmed by new study
11. Study casts doubt on keyboard ills
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... ... March 29, 2017 , ... ... is growing as it continues developing an ANSI-approved, consensus-based American National Standard ... which plans to publish the first ANSI-approved GMP standard for dietary supplements ...
(Date:3/29/2017)... , ... March 29, 2017 , ... HealthCareMandA.com will host ... April 20, 2017, at 1:00 PM ET. A recording of the webinar will also ... Webinar Series. , Home health and hospice companies are still popular targets for healthcare ...
(Date:3/29/2017)... (PRWEB) , ... March 29, 2017 , ... ... of Gastrointestinal Oncology™ (SOGO™), a specialized continuing medical education conference for clinicians who ... at Intercontinental Time Square, New York. , The program will be led ...
(Date:3/28/2017)... CA (PRWEB) , ... March 28, 2017 , ... Tuesday, ... asking the American public to take the Diabetes Risk Test to find out if ... the Los Angeles World Airports will light up the evening sky by programming the ...
(Date:3/28/2017)... ... March 28, 2017 , ... Revolution for Truth has organized ... protect parental rights and civil liberties, and to restore transparency within government agencies ... coincides with a press conference taking place Friday morning calling on President Trump ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... SILVER SPRING, Md. , March 29, 2017 On ... Ocrevus (ocrelizumab) to treat adult patients with relapsing forms ... (PPMS). This is the first drug approved by the ... by a health care professional.  "Multiple ... life," said Billy Dunn , M.D., director of ...
(Date:3/29/2017)... 29, 2017 /PRNewswire/ - Medicure Inc. ("Medicure") (TSXV:MPH, OTC:MCUJF), ... for the year ended December 31, 2016 after ... results are being released later than the previous ... include the operations and balances of Apicore from ... release and filing date meets TSX Venture Exchange ...
(Date:3/29/2017)... 29, 2017 Research and Markets has announced ... Software Market Outlook: 2016-2022" report to their offering. ... The global patient safety ... of delivery, end-user, and geography. Patient safety has ... globe. The field has developed significantly in the last decade and ...
Breaking Medicine Technology: